These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32267932)

  • 1. LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.
    Keane C; Law SC; Gould C; Birch S; Sabdia MB; Merida de Long L; Thillaiyampalam G; Abro E; Tobin JW; Tan X; Xu-Monette ZY; Young KH; Gifford G; Gabreilli S; Stevenson WS; Gill A; Talaulikar D; Jain S; Hernandez A; Halliday SJ; Bird R; Cross D; Hertzberg M; Gandhi MK
    Blood Adv; 2020 Apr; 4(7):1367-1377. PubMed ID: 32267932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients.
    Liu Y; Guo X; Zhan L; Wang L; Wang X; Jiang M
    Comput Math Methods Med; 2021; 2021():4468140. PubMed ID: 34422089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
    Naimy S; Bzorek M; Eriksen JO; Løvendorf MB; Litman T; Dyring-Andersen B; Gjerdrum LMR
    Dermatology; 2024; 240(1):156-163. PubMed ID: 37952520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
    Gould C; Lickiss J; Kankanige Y; Yerneni S; Lade S; Gandhi MK; Chin C; Yannakou CK; Villa D; Slack GW; Markham JF; Tam CS; Nelson N; Seymour JF; Dickinson M; Neeson PJ; Westerman D; Blombery P
    Br J Haematol; 2021 Oct; 195(1):113-118. PubMed ID: 34426978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.
    Parkhi M; Chatterjee D; Bal A; Vias P; Yadav BS; Prakash G; Gupta SK; Radotra BD
    APMIS; 2022 Feb; 130(2):82-94. PubMed ID: 34862664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma: the significance of CD8
    Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
    J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
    Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
    Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma.
    Gebauer F; Krämer M; Bruns C; Schlößer HA; Thelen M; Lohneis P; Schröder W; Zander T; Alakus H; Buettner R; Loeser H; Quaas A
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2319-2327. PubMed ID: 32592066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells.
    Ma J; Yan S; Zhao Y; Yan H; Zhang Q; Li X
    Front Immunol; 2023; 14():1265255. PubMed ID: 37841254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3
    Zhang T; Ren T; Song Z; Zhao J; Jiao L; Zhang Z; He J; Liu X; Qiu L; Li L; Zhou S; Meng B; Zhai Q; Ren X; Qian Z; Wang X; Zhang H
    J Immunol Res; 2020; 2020():6968595. PubMed ID: 33178839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
    Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
    Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas.
    Arolt C; Meyer M; Ruesseler V; Nachtsheim L; Wuerdemann N; Dreyer T; Gattenlöhner S; Wittekindt C; Buettner R; Quaas A; Klussmann JP
    Cancer Immunol Immunother; 2020 Jul; 69(7):1363-1373. PubMed ID: 32232506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma.
    Lee H; Yoon SE; Kim SJ; Kim WS; Cho J
    Cancer Med; 2023 Aug; 12(15):16359-16369. PubMed ID: 37326144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
    Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
    Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of CD8
    Zhu Q; Yang Y; Zeng Y; Chen K; Zhang Q; Wang L; Huang Y; Jian S
    Int Immunopharmacol; 2024 Aug; 137():112447. PubMed ID: 38909497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Sun Y; Liu C; Jiao T; Xie N; Wang H; Qi W; Shao Z
    Int J Hematol; 2020 Dec; 112(6):757-763. PubMed ID: 32785818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.